The Hague, Xinhua News Agency, November 24 (Reporter Wang Xiangjiang) The European Medicines Agency said on the 24th that with the arrival of winter and the rapid mutation of the new coronavirus, high-risk groups such as those over 60 years old and those with weakened immune functions should receive the new crown vaccine in time to strengthen their immunity. Needle.
Marco Cavaleri, director of vaccine strategy at the European Medicines Agency, said at an online press conference that day that the new coronavirus is still "maintaining a rapid mutation rate", and new subtypes of the Omicron strain such as BQ. The increasing and replacing subtype BA.5 of the currently circulating Omicron strain, these new subtypes are more capable of immune evasion and growth, which may render some antibody therapies ineffective.
Cavaleri pointed out that the booster vaccination rate in the EU area in the past few months has been "disappointing", with an average of only 29% of high-risk groups receiving booster injections, which means that those who are most likely to suffer from severe illness have not been adequately treated. Protect. Increasing the booster vaccination rate of high-risk groups is crucial to curbing the rise in hospitalization rates in the future. People over the age of 60 have a significantly increased risk of developing severe disease after being infected with the new crown, and vaccines can save lives. All countries should continue to carry out vaccination work, and give priority to booster vaccination for high-risk groups.
Stephen Tilstrup, chief medical officer of the European Medicines Agency, said at a press conference that although the number of confirmed cases of new crowns in the EU has declined recently, the new crown epidemic is not over yet, and a large number of viruses are still spreading. High-risk groups face high risks and should receive booster vaccines in time.
(Editors in charge: Yu Yang, Cui Yue)
Share for more people to see
The news is published by EMEA Tribune & Peoples Daily Online